Mum­bai-based Lupin gets FDA warn­ing for two man­u­fac­tur­ing sites; Io­n­is pro­motes in­ot­ersen head as new COO

→ In­di­an drug man­u­fac­tur­er Lupin re­ceived a warn­ing let­ter from the FDA claim­ing that it had vi­o­lat­ed good man­u­fac­tur­ing prac­tices, the com­pa­ny dis­closed in a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER